期刊文献+

高泌乳素血症166例分析 被引量:15

An analysis of 166 patients with hyperprolactinemia
原文传递
导出
摘要 目的探讨高泌乳素血症(HPRL)的临床表现、治疗方法及其与泌乳素腺瘤的关系。方法分析同济大学附属东方医院神经外科自2005年1月至2010年1月确诊为HPRL的166例患者临床资料、激素指标,其中4年为回顾性分析,1年为前瞻性研究。结果大部分患者的年龄分布在20-40岁,月经不调是最常见的临床表现,见于141例患者(84.9%);其次是溢乳,见于114例患者(68.7%)。发病原因中,泌乳素微腺瘤见于62例患者(37.3%),无功能性垂体大腺瘤见于26例患者(15.7%)。泌乳素微腺瘤患者泌乳素水平为(161.2±60.6)ng/mL,和其他任一原因导致的HPRL患者泌乳素水平比较,差异均有统计学意义(P〈0.05)。结论泌乳素微腺瘤是HPRL最常见的病因,其次为特发性HPIU。单从血清泌乳素的水平并不能确定患者是否一定存在微腺瘤。 Objective To study the clinical manifestations and treatment methods of hyperprolactinemia (HPRL), a common disorder encountered in clinical practice, and explore its association with prolactinomas. Methods The clinical data, hormone profile and imaging data of 166 females with documented HPRL, admitted to our hospital from January 2005 to January 2010, for over a period of 5 years, including 4 years of retrospective analysis and 1 year of prospective study, were retrospectively analyzed. Results Most patients aged 20-40 with abnormal menstruation as their most common symptom; 141 patients (84.9%) appeared abnormal menstruation and 114 (68.7%) with galactorrhea. Microadenoma was noted in 62 patients (37.3%), nonfunctioning pituitary macroadenoma involved stalk occurred in 26 patients (15.7%). As compared with that in patients with idiopathic HPRL ([93.9±20.4] ng/mL), the level ofprolactin in patients with microprolactinoma ([161.2±60.6] ng/mL) was significantly higher (P〈0.05); as compared with that in patients with prolactin microadenoma, the level of prolactin in patients with domperidone caused drag-induced HPRL ([240.2±29.4] ng/mL) was obviously increased (P〈0.05). Conclusion We cannot confirm whether a HPRL patient has prolactinomas only through detecting the level ofprolactin. Microprolactinoma is the most common cause of HPRL, followed by idiopathic cause.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第9期934-937,共4页 Chinese Journal of Neuromedicine
关键词 泌乳素 高泌乳素血症 泌乳素微腺瘤 溴隐亭 Prolactin Hyperprolactinemia Microprolactinoma Bromocriptine
  • 相关文献

参考文献12

  • 1Souter I, Baltagi LM, Toth TL, et al. Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility[J]. Fertil Steril, 2010, 94(3): 1159-1162.
  • 2Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2011, 96 (2): 273-288.
  • 3Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas[J]. Clin Endocrinol (Oxf), 2006, 65(2): 265-273.
  • 4胡宜,刘云会.泌乳素型垂体腺瘤误诊为周围神经炎1例[J].实用医学杂志,2009,25(14):2394-2394. 被引量:1
  • 5Mancini T, Casanueva FF,Giustina A. Hyperprolactinemia and prolactinomas[J]. Endocrinol Metab Clin North Am, 2008, 37(1): 67-99.
  • 6Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas [J]. Clin Endocrinol (Oxf), 1994,41(3): 359-364.
  • 7Glezer A, Soares CR, Vieira JG, et al. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay[J]. J Clin Endocrinol Meta, 2006, 91 (3): 1048-1055.
  • 8Gibney J, Smith TP, McKenna TJ. The impact on clinicalpractice of routine screening for macroprolactin [J]. J Clin Endocrinol Meta, 2005, 90(7): 3927-3932.
  • 9蔡梅钦,秦峰,王辉,李文胜,凌聪,郭英.溴隐亭治疗垂体泌乳素腺瘤后并发脑脊液漏处理二例报道并文献复习[J].中华神经医学杂志,2010,9(3):288-290. 被引量:8
  • 10Prabhakar VK, Davis JR. Hyperprolactinaemia[J]. Best Pract Res Clin Obstet Gynaecol, 2008, 22(2): 341-353.

二级参考文献7

  • 1Baha M,Arafah B M.Medical management of hypopituitarism in patients with pituitary adenomas[J].Pituitary,2002,5(2):109-117.
  • 2Cooper M S,Stewart P M.Diagnosis and treatment of ACTH deficiency[J].Rev Endocr Metab Disord,2005,6(1):47-54.
  • 3Hassikou H,Tabache F,Safi S,et al.A case of myopathy associated with hypothyroidism and hyperprolactinaemia[J].Rev Med Interne,2007,28(6):429-431.
  • 4Leong KS, Foy PM, Swift AC, et al. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas[J]. Clin Endocrino (Oxf), 2000, 52( 1): 43-49.
  • 5Pascal-Viqneron V, Weryha G, Braun M, et al. Rhinorrhea and otorrhea: rare complications of the medical treatment in invasive prolactionmas[J]. Ann Endocrinol (Pads), 1994, 54(5): 347-351.
  • 6Bronstein MD, Musolino NR, Benabou S, et al. Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroplactinomas[J]. Surg Neurol, 1989, 32(5): 346-349.
  • 7Barlas O, Bavindir C, Hepgil K, et al. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature[J]. Surg Neurol, 1994, 41(6): 486-489.

共引文献7

同被引文献124

引证文献15

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部